Clinical Consultations: Improving Outcomes by Addressing Health Care Disparities in Heart Failure Care
November 9, 2022
November 9, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Merck Sharp & Dohme LLC.
- Physicians — maximum of 0.75 AMA PRA Category 1 Credits™
- Nurses — 0.75 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is directed toward cardiologists. Primary care providers, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with heart failure are also invited to participate.
This Clinical Consultations™ is a video-based program in which 2 experts discuss health disparities that negatively impact patients with heart failure. Access to care, insurance costs, and unintended bias are just some of the factors that contribute to the existence and persistence of these disparities. This engaging format is designed to help clinicians better recognize and take steps to address ethnic and racial disparities in heart failure, thereby forwarding progress to improve patient outcomes in heart failure.
- Upon completion of this activity, participants should be better able to:
- Describe the burden of existing healthcare disparities in heart failure care
- Apply the new universal definition and classification to the management of heart failure to at- risk populations
- Identify the determinants of health care disparities resulting in suboptimal patients care and poor outcomes
Johanna P. Contreras, MD, MSc, FACC, FAHA, FHFSA
Director Ambulatory Heart Failure Network
Director of Diversity
Mount Sinai Health System
New York, NY
Melvin R. Echols, MD, FACC, FHFSA, FASPC
Chief Diversity, Equity, and Inclusion Officer
American College of Cardiology
Associate Professor of Medicine
Division of Cardiovascular Disease
Associate Director, Cardiovascular Institute
Program Director, Cardiovascular Disease Fellowship
Morehouse School of Medicine
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.75 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
- Johanna P. Contreras, MD, MSc, FACC, FAHA, FHFSA
- Consultant: AstraZeneca, Boehringer-Ingelheim, Merck
- Melvin R. Echols, MD, FACC, FHFSA, FASPC has no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.